Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation
Leukemia ( IF 12.8 ) Pub Date : 2024-07-04 , DOI: 10.1038/s41375-024-02327-2 Philipp Ernst 1 , Jenny Rinke 1 , Georg-Nikolaus Franke 2 , Frank Dicker 3 , Torsten Haferlach 3 , Thomas Ernst 1 , Andreas Hochhaus 1
中文翻译：
具有非典型 e19a2 BCR::ABL1 转录本和 T315I 突变的慢性粒细胞白血病采用阿西米尼三线治疗后获得无治疗缓解
更新日期：2024-07-04
Leukemia ( IF 12.8 ) Pub Date : 2024-07-04 , DOI: 10.1038/s41375-024-02327-2 Philipp Ernst 1 , Jenny Rinke 1 , Georg-Nikolaus Franke 2 , Frank Dicker 3 , Torsten Haferlach 3 , Thomas Ernst 1 , Andreas Hochhaus 1
Affiliation
|
中文翻译：
具有非典型 e19a2 BCR::ABL1 转录本和 T315I 突变的慢性粒细胞白血病采用阿西米尼三线治疗后获得无治疗缓解
京公网安备 11010802027423号